TARS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.489200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.095600E-01
Normal-vs-Stage2
5.637400E-01
Normal-vs-Stage3
9.860800E-01
Normal-vs-Stage4
4.454200E-01
Stage1-vs-Stage2
4.074000E-01
Stage1-vs-Stage3
6.621800E-01
Stage1-vs-Stage4
5.099600E-01
Stage2-vs-Stage3
5.209400E-01
Stage2-vs-Stage4
9.426400E-01
Stage3-vs-Stage4
4.893600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.578600E-01
Normal-vs-AfricanAmerican
4.957200E-01
Normal-vs-Asian
7.766200E-01
Caucasian-vs-AfricanAmerican
6.410200E-01
Caucasian-vs-Asian
5.848800E-01
AfricanAmerican-vs-Asian
4.897000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.162000E-01
Normal-vs-Female
5.880600E-01
Male-vs-Female
7.725600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.760400E-01
Normal-vs-Age(41-60Yrs)
3.587800E-01
Normal-vs-Age(61-80Yrs)
6.670200E-01
Normal-vs-Age(81-100Yrs)
6.497800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.623600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.815600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.988400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.143500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.769600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.416000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.968400E-01
Normal-vs-Daily Drinker
8.954600E-01
Normal-vs-Weekly Drinker
5.509000E-01
Normal-vs-Occasional Drinker
3.227400E-01
Normal-vs-Social Drinker
4.000200E-01
Non Drinker-vs-Daily Drinker
7.455800E-01
Non Drinker-vs-Weekly Drinker
2.044200E-01
Non Drinker-vs-Occasional Drinker
2.809700E-02
Non Drinker-vs-Social Drinker
5.244000E-02
Daily Drinker-vs-Weekly Drinker
2.592000E-01
Daily Drinker-vs-Occasional Drinker
5.984000E-02
Daily Drinker-vs-Social Drinker
1.607380E-01
Weekly Drinker-vs-Occasional Drinker
9.104600E-01
Weekly Drinker-vs-Social Drinker
6.916200E-01
Occasional Drinker-vs-Social Drinker
6.369000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.947800E-01
Normal-vs-Grade 2
7.010200E-01
Normal-vs-Grade 3
7.249800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.952000E-01
Grade 1-vs-Grade 3
2.786600E-01
Grade 1-vs-Grade 4
6.947800E-01
Grade 2-vs-Grade 3
2.080400E-01
Grade 2-vs-Grade 4
7.010200E-01
Grade 3-vs-Grade 4
7.249800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.954600E-01
Normal-vs-NonDiabetic
5.968400E-01
Diabetic-vs-NonDiabetic
6.044000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.011400E-01
Normal-vs-NoPancreatitis
5.899800E-01
Pancreatitis-vs-NoPancreatitis
7.373000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.677800E-01
Normal-vs-N1
5.627000E-01
N0-vs-N1
7.888000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.665600E-01
Normal-vs-TP53-NonMutant
5.269200E-01
TP53-Mutant-vs-TP53-NonMutant
1.133680E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
